SeekInCure®
A panoramic view of cancer genomic landscape
cfDNA detection via NGS drawing the view of cancer genomic landscape
Cutting-edge multivariate algrithm
Genomics combined with proteomics,capturing the signal of cancer recurrence
Multidimensional fingerprint
CNA, Fragmentation and protein markers discovering the early cancer recurrence
Big date and Artificial intelligence
CRI model based on machine learning evaluating the risk of cancer recurrence precisely
Specifications
Indicated subjects: post-surgery cancer patients
Sample requirement: 10ml peripheral blood
TAT: 10 working days
Result readout: CRI (cancer recurrence index)
Sampling time:
Pre-test inquiry
Informed consent
Blood-draw
Testing
Analyzing + Interpretation
Reporting
Post-test consultation
Recruiting!
Contact
📍 11F, Building 2, DBH Life Sciences & Health Industrial Park 2028 Shenyan Road Yantian, Shenzhen, Guangdong 518000 China
📞 400-686-8501
📧 customerservice@